Thanchanit Thaipitakwong is currently a Senior Content Creator at HITAP, responsible for planning and delivering research communication to the public and developing content in various formats tailored to different audiences and platforms. With a background in pharmacy and experience in medical communication, she focuses on making complex academic c

Benjarin Santatiwongchai is Head of Communication for HITAP. Having studied BSc in Pharmacy from Mahidol University, her knowledge in current and emerging medical technologies and interventions has led her to become involved with Health Technology Assessment. In 2012, she completed her MSc in Health Economics at the University of York. She is now a

Abstract During COVID-19 pandemic, telemedicine was a strategy to facilitate healthcare service delivery minimizing the risk of direct exposure among people. In Thailand, the National Health Security Office has included telemedicine services under the Universal Coverage Scheme to support social d

In Thailand, the prevalence of chronic kidney disease (CKD) is 17.5% of the population (Ingsathit et al., 2010). According to Thailand’s National Health Security Office (2021), in each year, this public health agency spends approximately 10,000 million Baht in renal dialysis and 1,000 million Baht for the CKD treatment and other related expenses.

Kidney failure (KF)[1] is a life-threatening disease that requires either kidney transplantation or dialysis for survival (1, 2). As of 2019, it was estimated that globally, 1.4 million deaths occurred on account of chronic kidney disease (CKD) (3). The cost of treatment for KF is also high, leading to catastrophic household expenditure to househo

Diseases are caused by a range of risk factors, some of which are modifiable risk factors. Understanding the health cost burden associated with each modifiable risk factor can provide valuable insights for the health system, such as helping prioritize public health interventions that target the most harmful risk factors or designing programs that c

The Health Intervention and Technology Assessment Program (HITAP) was requested by the World Health Organization (WHO), on behalf of the Ministry of Health & Sports (MoHS), to provide technical assistance for completing its closure reports. This study will focus on conducting an evaluation

This report provides a summary of the fourth visit to Myanmar as part of this study. In preparation for data collection, a training was organized by the MoHS for supervisors and enumerators. HITAP delivered sessions on a sampling of villages, wards, and households, the manual for supervisors a

The Indonesian HTA Committee (InaHTAC) was formally renewed and continues its work as a facilitator of national HTA studies as of 2016. Under their oversight and technical support provided by iDSI, three HTA economic evaluation studies were completed from 2014-2016: the economic evaluation of

A series of 4 workshops are planned to be held over the course of the next 12 months in order to build capacity in health technology assessment (HTA) for a group of researchers from the HTAIn Technical Partners and resource hubs. These workshops will be delivered by the HTAIn, the iDSI, and PGIMER C